Document Details
Form
Filing Date
Feb 13, 2023
Document Date
Feb 09, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
LURKER NANCY
